Science Translational Medicine

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.

Science Translational Medicine

van der Wijst MGP, Vazquez SE, Hartoularos GC, Bastard P, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Mann SA, Lynch KL, Yun C, Havlir DV, Chamie G, Marquez C, Greenhouse B, Lionakis MS, Norris PJ, Dumont LJ, Kelly K, Zhang P, Zhang Q, Gervais A, Le Voyer T, Whatley A, Si Y, Byrne A, Combes AJ, Rao AA, Song YS, Fragiadakis GK, Kangelaris K, Calfee CS, Erle DJ, Hendrickson C, Krummel MF, Woodruff PG, Langelier CR, Casanova JL, Derisi JL, Anderson MS, Ye CJ, UCSF COMET consortium

Raff-ining our understanding of pneumococcal invasion

Science Translational Medicine

Langelier, Chaz

Raff-ining our understanding of pneumococcal invasion

Science Translational Medicine

Langelier, Chaz

Raff-ining our understanding of pneumococcal invasion

Science Translational Medicine

Langelier, Chaz

Raff-ining our understanding of pneumococcal invasion

Science Translational Medicine

Langelier, Chaz

Raff-ining our understanding of pneumococcal invasion

Science Translational Medicine

Langelier, Chaz

Raff-ining our understanding of pneumococcal invasion

Science Translational Medicine

Langelier, Chaz

Raff-ining our understanding of pneumococcal invasion

Science Translational Medicine

Langelier, Chaz

A high five for TB screening

Science Translational Medicine

Langelier, C.

The resistance potential of a quintessential commensal

Science Translational Medicine

Langelier, Chaz

Pages